Search
Related
Audiovestibular Dysfunction Associated with Adoptive Cell Immunotherapy for Melanoma.
Seaman BJ, Guardiani EA, Brewer CC, Zalewski CK, King KA, Rudy S, Van Waes C, Morgan RA, Dudley ME, Yang JC, Rosenberg SA, Kim HJ.
Otolaryngol Head Neck Surg. 2012 May 17. [Epub ahead of print
22597578
[PubMed - as supplied by publisher] nohighlight
Related citations
Breast Cancer Suppressor Candidate-1 (BCSC-1) is a Melanoma Tumor Suppressor that Down Regulates MITF.
Anghel SI, Rocha RC, Budinska E, Boligan KF, Abraham S, Colombetti S, Fontao L, Mariotti A, Rimoldi D, Ghanem GE, Fisher DE, Bracco L, Lévy F, Delorenzi M, Piguet V.
Pigment Cell Melanoma Res. 2012 May 17. doi: 10.1111/j.1755-148X.2012.01018.x. [Epub ahead of print
22594792
[PubMed - as supplied by publisher] nohighlight
Related citations
A Right Atrial Mass in a Patient With Metastatic Melanoma and Prostate Cancer.
Maxwell BG, Forrester M, Wagner MJ.
J Cardiothorac Vasc Anesth. 2012 May 14. [Epub ahead of print] No abstract available.
22592136
[PubMed - as supplied by publisher] nohighlight
Related citations
Surgery for Distant Metastatic Melanoma Improves Survival.
Kroon BB.
Ann Surg Oncol. 2012 May 17. [Epub ahead of print] No abstract available.
22588471
[PubMed - as supplied by publisher] nohighlight
Related citations
Increased HOX C13 expression in metastatic melanoma progression.
Cantile M, Scognamiglio G, Anniciello A, Farina M, Gentilcore G, Santonastaso C, Fulciniti F, Cillo C, Franco R, Ascierto PA, Botti G.
J Transl Med. 2012 May 14;10(1):91. [Epub ahead of print
22583695
[PubMed - as supplied by publisher] Free Article nohighlight
Related citations
Cellular and molecular evidence for malignancy inhibitory functions of p15RS.
Zhang X, Cao Q, Liu X, Liu S, Wang J, Sun S, Wang O, Tian Z, Liu H, Kuang J, Zhang W.
Cell Cycle. 2012 May 15;11(10). [Epub ahead of print
22580456
[PubMed - as supplied by publisher] nohighlight
Related citations
The role of radiation therapy in the management of metastatic melanoma in the brain.
Hong A, Fogarty G, Izard MA.
Int J Surg Oncol. 2012;2012:294735. Epub 2012 Apr 11
22577532
[PubMed - in process] Free PMC Article nohighlight
Related citations
Tumor-specific CD4+ Melanoma Tumor-infiltrating Lymphocytes.
Friedman KM, Prieto PA, Devillier LE, Gross CA, Yang JC, Wunderlich JR, Rosenberg SA, Dudley ME.
J Immunother. 2012 Jun;35(5):400-8
22576345
[PubMed - in process] nohighlight
Related citations
Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial.
Burmeister BH, Henderson MA, Ainslie J, Fisher R, Di Iulio J, Smithers BM, Hong A, Shannon K, Scolyer RA, Carruthers S, Coventry BJ, Babington S, Duprat J, Hoekstra HJ, Thompson JF.
Lancet Oncol. 2012 May 8. [Epub ahead of print
22575589
[PubMed - as supplied by publisher] nohighlight
Related citations
Conformationally Constrained Peptides as Protein Tyrosine Kinase Inhibitors.
Tiwari RK, Parang K.
Curr Pharm Des. 2012 May 7. [Epub ahead of print
22571654
[PubMed - as supplied by publisher] nohighlight
Related citations
Side effects of systemic oncological therapies in dermatology.
Zimmer L, Vaubel J, Livingstone E, Schadendorf D.
J Dtsch Dermatol Ges. 2012 May 9. doi: 10.1111/j.1610-0387.2012.07942.x. [Epub ahead of print
22571234
[PubMed - as supplied by publisher] nohighlight
Related citations
Survivin-specific T-cell reactivity correlates with tumor response and patient survival: a phase-II peptide vaccination trial in metastatic melanoma.
Becker JC, Andersen MH, Hofmeister-Müller V, Wobser M, Frey L, Sandig C, Walter S, Singh-Jasuja H, Kämpgen E, Opitz A, Zapatka M, Bröcker EB, Thor Straten P, Schrama D, Ugurel S.
Cancer Immunol Immunother. 2012 May 8. [Epub ahead of print
22565484
[PubMed - as supplied by publisher] nohighlight
Related citations
Eruptive Squamous Cell Carcinomas Associated with BRAF-Inhibitor Therapy in a Patient with Metastatic Melanoma.
Ezra N, Hamid O, Behroozan D.
Dermatol Surg. 2012 May 7. doi: 10.1111/j.1524-4725.2012.02396.x. [Epub ahead of print] No abstract available.
22563699
[PubMed - as supplied by publisher] nohighlight
Related citations
The Abscopal Effect Associated With a Systemic Anti-melanoma Immune Response.
Stamell EF, Wolchok JD, Gnjatic S, Lee NY, Brownell I.
Int J Radiat Oncol Biol Phys. 2012 May 5. [Epub ahead of print
22560555
[PubMed - as supplied by publisher] nohighlight
Related citations
A case of vemurafenib-induced keratosis pilaris-like eruption.
Wang CM, Fleming KF, Hsu S.
Dermatol Online J. 2012 Apr 15;18(4):7
22559022
[PubMed - in process] Free Article nohighlight
Related citations
The role of BRAF V600 mutation in melanoma.
Ascierto PA, Kirkwood JM, Grob JJ, Simeone E, Grimaldi AM, Maio M, Palmieri G, Testori A, Marincola FM, Mozzillo N.
J Transl Med. 2012 May 3;10(1):85. [Epub ahead of print
22554099
[PubMed - as supplied by publisher] Free Article nohighlight
Related citations
Sentinel lymph node biopsy in thick malignant melanoma: A 10-year single unit experience.
Fairbairn NG, Orfaniotis G, Butterworth M.
J Plast Reconstr Aesthet Surg. 2012 May 1. [Epub ahead of print
22552263
[PubMed - as supplied by publisher] nohighlight
Related citations
Severe colitis while responding to ipilimumab in metastatic melanoma.
Slingerland M, Nortier JW, Veenendaal RA, Kapiteijn E.
Acta Oncol. 2012 May 2. [Epub ahead of print] No abstract available.
22551308
[PubMed - as supplied by publisher] nohighlight
Related citations
The next challenge in cancer immunotherapy: controlling T-cell traffic to the tumor.
Abastado JP.
Cancer Res. 2012 May 1;72(9):2159-61
22549945
[PubMed - in process] nohighlight
Related citations
L1CAM from human melanoma carries a novel type of N-glycan with Galβ1-4Galβ1- motif. Involvement of N-linked glycans in migratory and invasive behaviour of melanoma cells.
Hoja-Łukowicz D, Link-Lenczowski P, Carpentieri A, Amoresano A, Pocheć E, Artemenko KA, Bergquist J, Lityńska A.
Glycoconj J. 2012 Apr 29. [Epub ahead of print
22544341
[PubMed - as supplied by publisher] nohighlight
Related citations